Skip to main content
  • Management
      |Management
    • Compensation
    • Economics
    • Leadership
    • Legal News
    • Mergers & Acquisitions
    • Patient Care
    • Policy & Regulations
    • Practice Management
    • Professional Associations
    • Quality
    • Staffing
  • Imaging
      |Imaging
    • CT
    • MRI
    • Nuclear Medicine
    • Ultrasound
    • Women's Imaging
    • X-ray
  • Technology
      |Technology
    • Artificial Intelligence
    • Enterprise Imaging
    • Imaging Informatics
    • Informatics
    • PACS
  • Videos
  • Conferences
      |Conferences
    • ACR
    • AHRA
    • ARRS
    • ASRT
    • RBMA
    • RSNA
    • SBI
    • SCCT
    • SIIM
    • SIR
    • SNMMI
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025
    • Class of 2024

Search form

Home

News You Need to Know Today
Fluorescent contrast agent helps spot skin cancer | Needle left in patient after imaging delay | A radiotracer docs can 'hear'
Monday, August 25, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Hospital apologizes after imaging delay results in needle being left in patient

The organization is under fire after the patient’s wife charged that it could have prevented her husband’s untimely death. 

READ MORE >
artificial intelligence AI in healthcare
Share on Twitter Share on Facebook Share on Linkedin

Hospital apologizes after imaging delay results in needle being left in patient

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence AI in healthcare
The organization is under fire after the patient’s wife charged that it could have prevented her husband’s untimely death. 
READ MORE >

Fluorescent contrast agent noninvasively identifies common skin cancer

When used topically, the agent penetrates the skin and generates a fluorescent signal under the guidance of a fluorescent confocal microscope.

READ MORE >
Fluorescent contrast agent helps diagnose basal cell carcinoma.
Share on Twitter Share on Facebook Share on Linkedin

Fluorescent contrast agent noninvasively identifies common skin cancer

Share on Twitter Share on Facebook Share on Linkedin
Fluorescent contrast agent helps diagnose basal cell carcinoma.
When used topically, the agent penetrates the skin and generates a fluorescent signal under the guidance of a fluorescent confocal microscope.
READ MORE >

Surgeons can 'hear' cancerous lesions with help of new dual-mode radiotracer

When used during surgery, it can help providers identify cancerous lesions that are not in their immediate vision. 

READ MORE >
Dual-mode radiotracer helps surgeons 'hear' invisible cancer lesions
Share on Twitter Share on Facebook Share on Linkedin

Surgeons can 'hear' cancerous lesions with help of new dual-mode radiotracer

Share on Twitter Share on Facebook Share on Linkedin
Dual-mode radiotracer helps surgeons 'hear' invisible cancer lesions
When used during surgery, it can help providers identify cancerous lesions that are not in their immediate vision. 
READ MORE >

In Case You Missed It

New MRI findings may explain why some amputees struggle with phantom pain

New research refutes the notion that parts of the brain controlling specific extremities remap themselves following amputation, which would prevent patients from feeling pain associated with the removed appendage. 

READ MORE >
prosthetic.jpg
Share on Twitter Share on Facebook Share on Linkedin

New MRI findings may explain why some amputees struggle with phantom pain

Share on Twitter Share on Facebook Share on Linkedin
prosthetic.jpg
New research refutes the notion that parts of the brain controlling specific extremities remap themselves following amputation, which would prevent patients from feeling pain associated with the removed appendage. 
READ MORE >

New hypertension management recs support use of interventional radiology procedure

In patients with treatment-resistant hypertension, the procedure has the potential to produce sustained blood pressure reductions for 36 months or longer. 

READ MORE >
The U.S. Food and Drug Administration (FDA) has approved Recor Medical’s Paradise Ultrasound Renal Denervation (RDN) system for uncontrolled hypertension. The Recor system gained FDA clearance in November 2023.
Share on Twitter Share on Facebook Share on Linkedin

New hypertension management recs support use of interventional radiology procedure

Share on Twitter Share on Facebook Share on Linkedin
The U.S. Food and Drug Administration (FDA) has approved Recor Medical’s Paradise Ultrasound Renal Denervation (RDN) system for uncontrolled hypertension. The Recor system gained FDA clearance in November 2023.
In patients with treatment-resistant hypertension, the procedure has the potential to produce sustained blood pressure reductions for 36 months or longer. 
READ MORE >

Ultrasound use during IUD removals is on the rise

Removals are routinely completed in outpatient offices, but occasionally when complications make them more challenging, providers turn to additional tools for assistance. 

READ MORE >
interventional ultrasound
Share on Twitter Share on Facebook Share on Linkedin

Ultrasound use during IUD removals is on the rise

Share on Twitter Share on Facebook Share on Linkedin
interventional ultrasound
Removals are routinely completed in outpatient offices, but occasionally when complications make them more challenging, providers turn to additional tools for assistance. 
READ MORE >

In Other News

Healthcare AI today: 95% fail rate, epic at Epic, AI to the rescue of short staffs, more

Most organizations trying out generative AI—a full 95%—are failing to receive a measurable return on the pilot investment. 

READ MORE >
artificial intelligence disappointing ROI
Share on Twitter Share on Facebook Share on Linkedin

Healthcare AI today: 95% fail rate, epic at Epic, AI to the rescue of short staffs, more

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence disappointing ROI
Most organizations trying out generative AI—a full 95%—are failing to receive a measurable return on the pilot investment. 
READ MORE >

MGMA raises alarm over 2026 Medicare Physician Fee Schedule, warns of access crisis

Many make federal reimbursement plans into an issue about high-paid specialists complaining about pay cuts, but these fees also compensate nurses, technicians, support staff and administrators. Payment keeps the doors of brick-and-mortar medical practices open, MGMA warns.

READ MORE >
nders Gilberg, MGA, senior vice president, government affairs at Medical Group Management Association (MGMA), shares concerns about the draft fee schedule published in July. Congress was poised to reverse part of the cut in physician pay last December, but Elon Musk intervened and no fix was made. Congress instead made promises to help in 2026, but MGMA says it is not enough.
Share on Twitter Share on Facebook Share on Linkedin

MGMA raises alarm over 2026 Medicare Physician Fee Schedule, warns of access crisis

Share on Twitter Share on Facebook Share on Linkedin
nders Gilberg, MGA, senior vice president, government affairs at Medical Group Management Association (MGMA), shares concerns about the draft fee schedule published in July. Congress was poised to reverse part of the cut in physician pay last December, but Elon Musk intervened and no fix was made. Congress instead made promises to help in 2026, but MGMA says it is not enough.
Many make federal reimbursement plans into an issue about high-paid specialists complaining about pay cuts, but these fees also compensate nurses, technicians, support staff and administrators. Payment keeps the doors of brick-and-mortar medical practices open, MGMA warns.
READ MORE >

Smartwatches reduce physician burnout while improving resilience

Radiation oncologists and other specialists wore the devices for six months at two pilot institutions, with promising initial results. 

READ MORE >
The KardiaBand device from AliveCor is a more reliable tool for identifying atrial fibrillation (AFib) than the Apple Watch 4, according to a new head-to-head analysis published in JACC: Clinical Electrophysiology.
Share on Twitter Share on Facebook Share on Linkedin

Smartwatches reduce physician burnout while improving resilience

Share on Twitter Share on Facebook Share on Linkedin
The KardiaBand device from AliveCor is a more reliable tool for identifying atrial fibrillation (AFib) than the Apple Watch 4, according to a new head-to-head analysis published in JACC: Clinical Electrophysiology.
Radiation oncologists and other specialists wore the devices for six months at two pilot institutions, with promising initial results. 
READ MORE >

Nuclear imaging company Positron moves to New York for ‘exciting new chapter’

Positron made the move to help its case when it files an official Form 10 registration statement with the SEC.

READ MORE >
Positron NeuSight PET-CT 64 slice scanner
Share on Twitter Share on Facebook Share on Linkedin

Nuclear imaging company Positron moves to New York for ‘exciting new chapter’

Share on Twitter Share on Facebook Share on Linkedin
Positron NeuSight PET-CT 64 slice scanner
Positron made the move to help its case when it files an official Form 10 registration statement with the SEC.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Best of the Week: MRI links anxiety to brain changes | AI equals rads at prostate cancer detection | 4 deaths prompt US recall
Senate bill would slash radiology spending | MRI links ultraprocessed foods to brain injury | New imaging clinic chain launches
How departments are reducing wait times | Program increases exposure to radiology careers | Gaps in radiation safety knowledge
A warning about BI-RADS | 3-step buyer's guide for radiology AI | IR procedure reduces steroid reliance for KOA | Rad turnover
Radiologists worry of ripple effect after false claims | AI matches rads at prostate cancer detection | Rad Partners scores win
GE HealthCare acquiring radiopharma firm | RP seeks to expand teleradiology services | Telix and ITM merge in $1.65B deal | More
Siemens Healthineers ends general ultrasound sales | More liver cancer patients turning to IR treatments | Anxiety on MRI
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup